Platelet-derived growth factor (PDGF)-induced chemotaxis does not require the G protein-coupled receptor S1P1 in murine embryonic fibroblasts and vascular smooth muscle cells  by Kluk, Michael J. et al.
Platelet-derived growth factor (PDGF)-induced chemotaxis does not
require the G protein-coupled receptor S1P1 in murine embryonic
¢broblasts and vascular smooth muscle cells
Michael J. Kluk, Chantal Colmont, Ming-Tao Wu, Timothy Hla
Center for Vascular Biology, Department of Physiology, MC3501, University of Connecticut Health Center, 263 Farmington Ave.,
Farmington, CT 06030-3501, USA
Received 7 October 2002; revised 19 November 2002; accepted 19 November 2002
First published online 2 December 2002
Edited by Guido Tettamanti
Abstract Sphingosine 1-phosphate (S1P), a bioactive lipid me-
diator, signals via G protein-coupled receptors (GPCR). The
prototypical S1P receptor, S1P1 (also known as EDG-1), a
Gi-linked receptor, is critical for vascular maturation during
development. Recent work suggested that platelet-derived
growth factor (PDGF)-induced cell migration required the
S1P1 receptor, representing a novel mechanism for cross-talk
between receptor tyrosine kinases and GPCRs. Since both S1P
and PDGF are implicated in vascular smooth muscle cell
(VSMC) pathobiology and development, we investigated this
issue in rat VSMC and in embryonic ¢broblasts derived from
S1P1 null mice. Our data suggest that the S1P1 receptor is
critical for S1P-induced, Gi-dependent migration but not for
PDGF-BB-induced, receptor tyrosine kinase-dependent chemo-
taxis in VSMC. In addition, lack of S1P1 receptor in mouse
embryonic ¢broblasts did not signi¢cantly a¡ect PDGF-induced
cell migration. These data question the generality of the concept
that S1P1 GPCR is a critical downstream component of PDGF-
induced chemotaxis.
0 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The migration of vascular smooth muscle cells (VSMC) is
an important aspect of blood vessel development [1^4] and
cardiovascular disease [5^8]. Many polypeptide growth factors
regulate VSMC migration [9,10], especially platelet-derived
growth factor (PDGF) [5^7,11].
In addition, the platelet-derived bioactive lipid sphingosine
1-phosphate (S1P) has been demonstrated to regulate VSMC
migration. Originally, S1P was shown to inhibit the migration
of human VSMC [12]. However, further investigation has re-
vealed that S1P can induce the migration of VSMC if they
express the S1P1 receptor, a G protein-coupled receptor
(GPCR) originally known as endothelial di¡erentiation gene
(EDG)-1 [13,14]. In addition, antagonistic signaling between
S1P1 and S1P2 receptors was shown to be critical for S1P-
induced VSMC migration, as these di¡erent receptors regulate
migration pathways in an opposite manner [15,16].
Recently, cross-talk between the S1P and PDGF signaling
pathways has been proposed [14,17,18]. Hobson et al. [18]
proposed a model that included a critical requirement for
the S1P1 GPCR in PDGF-induced cell migration. In this
model, PDGF-BB, a high-a⁄nity ligand for the receptor ty-
rosine kinase PDGF-L receptor, induced the intracellular ac-
tivation of sphingosine kinase enzyme, followed by the acti-
vation of S1P1 receptor in an autocrine manner. This event
was shown to be critical for activation of chemotaxis signaling
pathways, such as the stimulation of the small GTPase Rac.
The authors argued that this might be a physiologically im-
portant mechanism, as both PDGF-L and S1P1 receptor gene
deletion studies resulted in vascular maturation defects in
mice. In a second study, Alderton et al. [17] proposed that
S1P1 is critical for PDGF-induced mitogen-activated protein
(MAP) kinase activation in airway smooth muscle cells. Over-
expression of PDGF-L receptor and S1P1 receptor in human
embryonic kidney (HEK) 293 cells resulted in co-precipitation
of the two receptors, suggesting that S1P1 is an important
component of PDGF-induced MAP kinase activation. These
proposals are novel in that they suggest cross-communication
between receptor tyrosine kinases and GPCRs [17]. However,
some aspects of the model, such as the pertussis toxin sensi-
tivity of PDGF-induced migration, have recently been ques-
tioned [14].
In an attempt to improve our understanding of the poten-
tial involvement of S1P1 in PDGF-induced migration, we in-
vestigated the cultured VSMC cells from rat aorta, a model
system widely used in studies of VSMC pathobiology [19].
Contrary to the previous studies, we show that S1P1 expres-
sion is not critical for PDGF-BB-induced VSMC migration.
2. Materials and methods
2.1. Materials
S1P (Biomol) was prepared as previously described [13]. Recombi-
nant human PDGF-BB (RpD Systems) was resuspended in 4 mM
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HCl with 0.1% fatty acid-free bovine serum albumin (BSA). Pertussis
toxin (Calbiochem) was resuspended in phosphate bu¡er.
2.2. Cell culture
The following cell lines were used in this study: (a) rat adult medial
VSMC [13,19]. These cells express S1P2 and S1P3 receptors and un-
detectable S1P1 receptor [13]. In addition, S1P1 3/3 mouse embryo
¢broblasts were derived as described below. These cells express S1P2
and S1P3 receptors as described before [3]. In some experiments, cells
were infected with adenoviral constructs expression S1P1 receptor as
described previously [25]. To determine the e¡ect of increasing the
receptor expression level, cells were infected with increasing numbers
of viral particles, as determined by multiplicity of infection (MOI)
units. An MOI is de¢ned as one viable particle of adenovirus per
host cell.
Rat adult medial VSMC were maintained and infected with adeno-
virus as described previously [13]. Heterozygous S1P1 knockout mice
were generously provided by R. Proia (NIH) [3]. They were crossed to
obtain embryos of di¡erent genotypes. Mouse embryonic ¢broblasts
were prepared from 12.5 day embryos (of all three genotypes, namely,
+/+, +/3 and 3/3) by removing the head and liver and homogenizing
the remaining embryo through a needle and syringe. Although +/+
and +/3 embryos were healthy at the time, occasional bleeding was
seen in 3/3 embryos. However, at all times only embryos that were
alive (de¢ned as those with a beating heart) were used for the isolation
of cells. Genotyping was done by extracting DNA from yolk sacs. Cell
cultures were maintained in Dulbecco’s modi¢ed Eagle’s medium
(DMEM), 10% fetal bovine serum with antibiotics and were geno-
typed as described previously [3].
2.3. Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA was isolated from cells using the RNA-Stat 60 reagent
(Tel Test). In some experiments, poly-Aþ RNA was prepared using
the oligo-dT cellulose chromatography as described previously [24].
RNA was reversed-transcribed and PCR was performed to determine
the expression of S1P1, S1P2/EDG-5 and S1P3/EDG-3 using the prim-
ers and conditions described [20]. Ampli¢ed products were analyzed
by agarose gel electrophoresis and ethidium bromide staining.
2.4. Migration assays
Rat adult medial VSMC were used in migration assay as described
previously [13]. Mouse embryonic ¢broblasts were serum-starved
overnight in DMEM with 0.5% charcoal-stripped serum. The next
day, cells were trypsinized, resuspended in DMEM with 0.5% fatty
acid-free BSA and loaded into the upper chambers. The lower cham-
bers were loaded with DMEM, 0.5% fatty acid-free BSA alone or
supplemented with PDGF (10 ng/ml). Fibroblasts were allowed to
migrate for 6 h and then were quantitated as described elsewhere [21].
3. Results and discussion
We compared the migration of rat VSMC which express
di¡erent levels of S1P1 receptor. As previously described, rat
adult medial VSMC abundantly express S1P3/EDG-3 and
S1P2/EDG-5 mRNA but do not express detectable S1P1
mRNA [13,15,22]. Expression of S1P1 in rat adult medial
VSMC has been shown to enhance proliferation and migra-
tion in response to S1P [13], however, in this system, the role
of S1P1 in PDGF-induced migration was not tested. Further-
more, a recent publication [18] suggests that S1P1 may play a
role in regulating PDGF-induced migration in HEK 293 cells,
mouse embryonic ¢broblasts and human VSMC. Therefore,
we tested whether expression of S1P1 in rat adult medial
VSMC would alter the migratory responses to PDGF.
Expression of S1P1 in adult medial VSMC by adenoviral
infection clearly enhanced migration toward S1P in a pertussis
toxin-sensitive manner (Fig. 1). However, expression of S1P1
did not enhance PDGF-induced migration and PDGF-in-
duced migration was not pertussis toxin-sensitive. These ¢nd-
ings suggest that the S1P1/Gi signaling pathway may not be
required for PDGF-induced migration.
In order to rule out the possibility that di¡erent levels of
S1P1 expression may in£uence PDGF receptor signaling, two
di¡erent MOIs for the S1P1 adenovirus were used in combi-
nation with di¡erent doses of PDGF. As seen in Fig. 2, the
S1P1 adenovirus infection clearly enhanced S1P-induced mi-
gration at both doses. However, PDGF-induced migration
Fig. 1. Rat adult medial VSMC were grown until 75^100% con£u-
ence and were infected with either S1P1 or L-galactosidase adenovi-
rus. Two days after infection, cell migration assay was conducted as
described. In some conditions, cells were pretreated with pertussis
toxin (PTX, 200 ng/ml) and migration toward S1P (5 nM) or
PDGF (40 ng/ml) was tested. Cell migration was quanti¢ed by mea-
suring absorbance at 575 nm. PB=PBS/BSA control. Data repre-
sent meanQS.D. Statistical signi¢cance was calculated using the un-
paired two-tailed t-test (*P=0.004 and **P=0.015).
Fig. 2. Rat adult medial VSMC were infected with L-galactosidase
or S1P1 adenovirus (MOI indicated in ¢gure legend) and migration
toward 5 nM S1P or various doses of PDGF was tested as de-
scribed. Increasing number of viral particles (as determined by in-
creasing MOI) is used to increase the level of S1P1 receptor.
PB=PBS/BSA control. Data represent meanQS.D. Statistical signif-
icance was calculated using the unpaired two-tailed t-test (*P=0.032
and **P=0.001). NS=not signi¢cant.
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was not enhanced even when multiple doses of PDGF (5^40
ng/ml) were used. Taken together, these results demonstrate
that the expression of S1P1 receptor does not enhance PDGF-
induced migration in rat VSMC and that PDGF-induced mi-
gration is not pertussis toxin-sensitive. Since S1P1 expression
is not detectable in adult medial VSMC, these data question
the generality of the concept that PDGF-induced chemotaxis
requires signal transduction from the S1P1 GPCR [18].
To further test the requirement for S1P1 in PDGF-induced
chemotaxis, we utilized several independent isolates of mouse
embryonic ¢broblasts (MEF) from wild-type and well as S1P1
3/3 mice [3]. The endogenous S1P1 gene was disrupted by
homologous recombination in these cells; therefore these cells
completely lack the S1P1 receptor [3]. We found that PDGF
clearly induced the migration of mouse embryonic ¢broblasts
isolated from both wild-type and S1P1 knockout mouse em-
bryos (Fig. 3). Interestingly, there appeared to be some var-
iation in migratory responses of ¢broblasts with the same ge-
notype isolated from di¡erent embryos. Nevertheless, the
average PDGF-induced migration of all wild-type ¢broblast
clones (5.72Q 0.97-fold increase above control) did not di¡er
signi¢cantly (P=0.244, unpaired t-test) from the average
PDGF-induced migration of the S1P1 knockout ¢broblasts
(4.50Q 0.38-fold increase above control). As expected, S1P1
was expressed in wild-type embryonic ¢broblasts but not in
¢broblasts isolated from S1P1 knockout mice (Fig. 3). These
data are in agreement with our ¢ndings from adult medial
VSMC that S1P1 receptor is not required for PDGF-induced
chemotaxis.
In conclusion, expression of S1P1 receptor in rat VSMC
enhanced S1P-induced migration in a pertussis toxin-sensitive
manner, consistent with signaling via the S1P1/Gi pathway.
However, expression of S1P1 in rat VSMC did not enhance
PDGF-induced migration and such migration was not pertus-
sis toxin-sensitive. These data are not consistent with the mod-
el proposed by Hobson et al. [18], where S1P1 was proposed
to be necessary for PDGF-induced migration. There may be
several reasons for the apparent discrepancies between our
results and those of Hobson et al. In the model proposed
by these authors, PDGF induced the activity of sphingosine
kinase enzyme, which produced the ligand S1P. In addition,
the authors further suggested that S1P is somehow exported
out of the cell and activated S1P1 receptor, resulting in the
activation of the chemotaxis program. Many of the conclu-
Fig. 3. A: PDGF-induced migration of wild-type embryonic ¢broblasts isolated from ¢ve di¡erent embryos and S1P1 knockout (3/3) embry-
onic ¢broblasts isolated from six di¡erent embryos are shown. The data represent several independent experiments with all conditions per-
formed in triplicate. Data represent meanQS.D. Statistical signi¢cance was calculated using the unpaired two-tailed t-test, and the P values did
not indicate signi¢cant di¡erences (P=0.244). B: The expression of S1P1, S1P3/EDG-3 and S1P2/EDG-5 mRNAs was determined by RT-PCR
using poly-Aþ RNA isolated from either wild-type or S1P1 knockout ¢broblasts. Shown here are the results for ¢broblasts isolated from two
di¡erent embryos of each genotype. Note that, as expected, wild-type ¢broblasts express mRNA for S1P1, S1P3/EDG-3 and S1P2/EDG-5 while
S1P1 knockout ¢broblasts express mRNA only for S1P3/EDG-3 and S1P2/EDG-5. 3=minus reverse transcriptase; +=plus reverse transcrip-
tase.
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sions of that study were based on the use of N,NP-dimethyl-
sphingosine, an inhibitor of sphingosine kinase that also in-
hibits other signaling proteins [18,23]. In addition, the authors
reported data on only one MEF cell line which may not be
truly representative. Analysis of several independent isolates
in our study did not reveal signi¢cant di¡erences in PDGF
sensitivity of S1P1 3/3 cell lines from the wild-type counter-
parts. It is also possible that sphingosine kinase activation in
the rat adult medial VSMC and MEF may be signi¢cantly
di¡erent from those employed by Hobson et al. [18]. Despite
these caveats, our data question the generality of the concept
that S1P1 is an essential downstream mediator of PDGF-in-
duced chemotaxis.
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